Skip to content
6-K

Foreign Interim / Material

INTELLIPHARMACEUTICS INTERNATIONAL INC.

0001654954-23-012272

← back to feed
Filed
Sep 26, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q2 2023 · May 31, 2023 $89.73K
Operating Cash Flow Q2 2023 · May 31, 2023 $75.55K
Operating Cash Flow Q2 2023 · May 31, 2022 −$338.57K
Operating Cash Flow Q2 2023 · May 31, 2022 −$899.15K
Stockholders Equity Q2 2023 · May 31, 2023 −$10.99M
Stockholders Equity Q2 2023 · Nov 30, 2022 −$10.58M
Stockholders Equity Q2 2023 · May 31, 2022 −$9.86M
Stockholders Equity Q2 2023 · Nov 30, 2021 −$8.16M
Current Liabilities Q2 2023 · May 31, 2023 $12.72M
Current Liabilities Q2 2023 · Nov 30, 2022 $12.01M
Current Assets Q2 2023 · May 31, 2023 $953.45K
Current Assets Q2 2023 · Nov 30, 2022 $492.51K
Total Assets Q2 2023 · May 31, 2023 $1.74M
Total Assets Q2 2023 · Nov 30, 2022 $1.43M
Sga Expense Q2 2023 · May 31, 2023 $93.5K
Sga Expense Q2 2023 · May 31, 2023 $232.34K
Sga Expense Q2 2023 · May 31, 2022 $243.5K
Sga Expense Q2 2023 · May 31, 2022 $504.36K
Rd Expense Q2 2023 · May 31, 2023 $377.51K
Rd Expense Q2 2023 · May 31, 2023 $825.67K
Rd Expense Q2 2023 · May 31, 2022 $956.85K
Rd Expense Q2 2023 · May 31, 2022 $1.43M
Net Income Q2 2023 · May 31, 2023 −$54.12K
Net Income Q2 2023 · May 31, 2023 −$409.86K
Net Income Q2 2023 · May 31, 2022 −$840.65K
Net Income Q2 2023 · May 31, 2022 −$1.72M
Operating Income Q2 2023 · May 31, 2023 −$31.36K
Operating Income Q2 2023 · May 31, 2023 −$332.76K
Operating Income Q2 2023 · May 31, 2022 −$1.25M
Operating Income Q2 2023 · May 31, 2022 −$2.02M
Revenue Q2 2023 · May 31, 2023 $480.2K
Revenue Q2 2023 · May 31, 2023 $806.55K
Revenue Q2 2023 · May 31, 2022 $0
Revenue Q2 2023 · May 31, 2022 $16.98K